These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 23052151
1. Recovery time after sugammadex reversal of rocuronium-induced muscle relaxation for electroconvulsive therapy is independent of cardiac output in both young and elderly patients. Kadoi Y, Nishida A, Saito S. J ECT; 2013 Mar; 29(1):33-6. PubMed ID: 23052151 [Abstract] [Full Text] [Related]
2. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex. Yoshida F, Suzuki T, Kashiwai A, Furuya T, Konishi J, Ogawa S. Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864 [Abstract] [Full Text] [Related]
3. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy. Kadoi Y, Hoshi H, Nishida A, Saito S. J Anesth; 2011 Dec; 25(6):855-9. PubMed ID: 21947754 [Abstract] [Full Text] [Related]
4. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME. Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792 [Abstract] [Full Text] [Related]
5. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study. Cammu G, Coart D, De Graeve K, Beelen R. Acta Anaesthesiol Belg; 2012 Mar; 63(2):69-73. PubMed ID: 23136807 [Abstract] [Full Text] [Related]
6. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial. Czarnetzki C, Tassonyi E, Lysakowski C, Elia N, Tramèr MR. Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361 [Abstract] [Full Text] [Related]
7. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, Hermens Y, Mirakhur RK. Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156 [Abstract] [Full Text] [Related]
8. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567 [Abstract] [Full Text] [Related]
9. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block. Pavoni V, Gianesello L, Martinelli C, Horton A, Nella A, Gori G, Simonelli M, De Scisciolo G. J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126 [Abstract] [Full Text] [Related]
10. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O, White PF, Tufanogullari B, Klein K. Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210 [Abstract] [Full Text] [Related]
11. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study. Yamamoto S, Yamamoto Y, Kitajima O, Maeda T, Suzuki T. Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400 [Abstract] [Full Text] [Related]
12. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy. Sungur Ulke Z, Yavru A, Camci E, Ozkan B, Toker A, Senturk M. Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983 [Abstract] [Full Text] [Related]
14. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, Wulf H. Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873 [Abstract] [Full Text] [Related]
15. The use of sugammadex in a patient with myasthenia gravis. Unterbuchner C, Fink H, Blobner M. Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151 [Abstract] [Full Text] [Related]
16. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Pongrácz A, Szatmári S, Nemes R, Fülesdi B, Tassonyi E. Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915 [Abstract] [Full Text] [Related]
17. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study. Ozmete O, Bali C, Cok OY, Turk HE, Ozyilkan NB, Civi S, Aribogan A. J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583 [Abstract] [Full Text] [Related]
19. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227 [Abstract] [Full Text] [Related]
20. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex. Staals LM, Driessen JJ, Van Egmond J, De Boer HD, Klimek M, Flockton EA, Snoeck MM. Acta Anaesthesiol Scand; 2011 Jul; 55(6):700-7. PubMed ID: 21574968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]